Shanahan-Phil is responsible for quality control, quality assurance and compliance at the Athlone, Ireland and Wilmington, Ohio sites, and the quality assurance function at the Waltham site. Dr. Shanahan joined Alkermes as Vice President, Quality Operations upon completion of the merger between Elan Drug Technologies (EDT) and Alkermes, Inc. in September 2011. Dr. Shanahan has more than 15 years of experience in quality operations. Prior to joining Elan, he served at Servier and Janssen Global Services, LLC. Dr. Shanahan obtained his doctorate in analytical biotechnology and his Bachelor of Science in chemistry from University College Cork. He holds a diploma in pharmaceutical manufacturing technology and is a certified Qualified Person (QP) for the release of product to the European Union. Shanahan-Phil is responsible for quality control, quality assurance and compliance at the Athlone, Ireland and Wilmington, Ohio sites, and the quality assurance function at the Waltham site. Dr. Shanahan joined Alkermes as Vice President, Quality Operations upon completion of the merger between Elan Drug Technologies (EDT) and Alkermes, Inc. in September 2011. Dr. Shanahan has more than 15 years of experience in quality operations. Prior to joining Elan, he served at Servier and Janssen Global Services, LLC. Dr. Shanahan obtained his doctorate in analytical biotechnology and his Bachelor of Science in chemistry from University College Cork. He holds a diploma in pharmaceutical manufacturing technology and is a certified Qualified Person (QP) for the release of product to the European Union.

Regulatory Affairs